Table 2.
Comparison of components of MS among BP groups.
| Variables | BP Group | Value | BP group | Value | P |
|---|---|---|---|---|---|
| SBP (mmHg) |
Normotension | 107.4 ± 4.8 | Pre-HTN | 122.0 ± 6.4 | <0.001† |
| Normotension | 107.4 ± 4.8 | Stage 1 HTN | 139.0 ± 8.6 | <0.001† | |
| Normotension | 107.4 ± 4.8 | Stage 2 HTN | 170.1 ± 25.5 | <0.001† | |
| Pre-HTN | 122.0 ± 6.4 | Stage 1 HTN | 139.0 ± 8.6 | <0.001† | |
| Pre-HTN | 122.0 ± 6.4 | Stage 2 HTN | 170.1 ± 25.5 | <0.001† | |
| Stage 1 HTN | 139.0 ± 8.6 | Stage 2 HTN | 170.1 ± 25.5 | <0.001† | |
|
| |||||
| DBP (mmHg) |
Normotension | 69.4 ± 2.9 | Pre-HTN | 76.6 ± 5.0 | <0.001† |
| Normotension | 69.4 ± 2.9 | Stage 1 HTN | 85.9 ± 6.2 | <0.001† | |
| Normotension | 69.4 ± 2.9 | Stage 2 HTN | 102.5 ± 12.8 | <0.001† | |
| Pre-HTN | 76.6 ± 5.0 | Stage 1 HTN | 85.9 ± 6.2 | <0.001† | |
| Pre-HTN | 76.6 ± 5.0 | Stage 2 HTN | 102.5 ± 12.8 | <0.001† | |
| Stage 1 HTN | 85.9 ± 6.2 | Stage 2 HTN | 102.5 ± 12.8 | <0.001† | |
|
| |||||
| WC (cm) | Normotension | 88.2 ± 12.0 | Pre-HTN | 92.6 ± 13.6 | 0.002† |
| Normotension | 88.2 ± 12.0 | Stage 1 HTN | 98.5 ± 12.4 | <0.001† | |
| Normotension | 88.2 ± 12.0 | Stage 2 HTN | 102.0 ± 12.7 | <0.001† | |
| Pre-HTN | 92.6 ± 13.6 | Stage 1 HTN | 98.5 ± 12.4 | <0.001† | |
| Pre-HTN | 92.6 ± 13.6 | Stage 2 HTN | 102.0 ± 12.7 | <0.001† | |
|
| |||||
| FPG (mmol/L) |
Normotension | 4.7 ± 1.4 | Stage 2 HTN | 5.0 ± 1.9 | 0.042† |
| Stage 1 HTN | 4.6 ± 0.9 | Stage 2 HTN | 5.0 ± 1.9 | 0.034† | |
|
| |||||
| TG (mmol/L) |
Normotension | 0.7 ± 0.3 | Stage 1 HTN | 0.8 ± 0.4 | 0.047† |
| Normotension | 0.7 ± 0.3 | Stage 2 HTN | 0.9 ± 0.4 | 0.001† | |
| Pre-HTN | 0.8 ± 0.4 | Stage 2 HTN | 0.9 ± 0.4 | 0.047† | |
P: probability, †: significant, values are in mean ± s.d, n: number of participants, BP: blood pressure, SBP: systolic blood pressure, DBP: diastolic blood pressure, WC: waist circumference, TG: Triglyceride, FPG: fasting plasma glucose, MS: metabolic syndrome, HTN: hypertension, number of participants in normotension, pre-HTN, stage 1 HTN, stage 2 HTN groups = 143, 197, 114, 80, respectively; total number of participants = 534.